CANY
TVRD

Caxton Associates (New York)’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Caxton Associates (New York)’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-610
Closed -$268K – 717
2021
Q4 		$268K Buy
+610
New +$268K 0.03% 419
2021
Q3 		– Sell
-491
Closed -$252K – 598
2021
Q2 		$252K Buy
+491
New +$252K 0.03% 338